Mobix Labs enters $15.8M at-the-market equity offering with Roth Capital

MOBIX LABS, INC

ATM agreement allows sale of up to $15.8M in Class A common stock at market prices.
Roth Capital will receive a 3% commission on gross proceeds; Company reimburses up to $75,000 in expenses.
Net proceeds intended for working capital purposes.
Sales will be made under effective shelf registration (File No. 333-284351) via Rule 415(a)(4).
Agreement dated October 21, 2025; shares trade on Nasdaq under MOBX and MOBXW.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.